Nikolaus Osterrieder

Nikolaus Osterrieder's AcademicInfluence.com Rankings

Biology

#13579

World Rank

#17131

Historical Rank

Developmental Biology

#181

World Rank

#189

Historical Rank

Virology

#341

World Rank

#348

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Nikolaus Osterrieder Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nikolaus Osterrieder's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. (2006) (757)
En passant mutagenesis: a two step markerless red recombination system. (2010) (503)
Marek's disease virus: from miasma to model (2006) (379)
Egress of Alphaherpesviruses: Comparative Ultrastructural Study (2001) (289)
Equine herpesvirus-1 consensus statement. (2009) (254)
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model (2020) (253)
The Interacting UL31 and UL34 Gene Products of Pseudorabies Virus Are Involved in Egress from the Host-Cell Nucleus and Represent Components of Primary Enveloped but Not Mature Virions (2002) (251)
Delivery of foreign antigens by engineered outer membrane vesicle vaccines (2010) (238)
Reconstitution of Marek's Disease Virus Serotype 1 (MDV-1) from DNA Cloned as a Bacterial Artificial Chromosome and Characterization of a Glycoprotein B-Negative MDV-1 Mutant (2000) (213)
A Point Mutation in a Herpesvirus Polymerase Determines Neuropathogenicity (2007) (197)
Evidence for Novel Hepaciviruses in Rodents (2013) (188)
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters (2020) (177)
Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I mediated immunity (2017) (156)
Oncogenicity of Virulent Marek's Disease Virus Cloned as Bacterial Artificial Chromosomes (2004) (133)
The Protein Encoded by the US3 Orthologue of Marek's Disease Virus Is Required for Efficient De-Envelopment of Perinuclear Virions and Involved in Actin Stress Fiber Breakdown (2005) (126)
SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals (2021) (123)
A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis (2006) (123)
Characterization of Marek's Disease Virus Serotype 1 (MDV-1) Deletion Mutants That Lack UL46 to UL49 Genes: MDV-1 UL49, Encoding VP22, Is Indispensable for Virus Growth (2002) (122)
Virus-induced senescence is a driver and therapeutic target in COVID-19 (2021) (120)
Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation (2011) (116)
Horizontal Transmission of Marek's Disease Virus Requires US2, the UL13 Protein Kinase, and gC (2007) (114)
A Self-Excisable Infectious Bacterial Artificial Chromosome Clone of Varicella-Zoster Virus Allows Analysis of the Essential Tegument Protein Encoded by ORF9 (2007) (113)
Attenuation of Marek's Disease Virus by Deletion of Open Reading Frame RLORF4 but Not RLORF5a (2005) (112)
Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). (2006) (108)
Marek’s disease virus: lytic replication, oncogenesis and control (2006) (104)
Codon Pair Bias Is a Direct Consequence of Dinucleotide Bias. (2016) (101)
Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)--masters of co-evolution and a constant threat to equids and beyond. (2013) (98)
Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984-2007). (2009) (96)
Replication-Competent Bacterial Artificial Chromosomes of Marek's Disease Virus: Novel Tools for Generation of Molecularly Defined Herpesvirus Vaccines (2003) (95)
Varicellovirus UL49.5 Proteins Differentially Affect the Function of the Transporter Associated with Antigen Processing, TAP (2008) (89)
The equine herpesvirus 1 glycoprotein gp21/22a, the herpes simplex virus type 1 gM homolog, is involved in virus penetration and cell-to-cell spread of virions (1996) (89)
A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation (2007) (87)
Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). (2002) (85)
Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). (1995) (81)
Herpesvirus Genome Integration into Telomeric Repeats of Host Cell Chromosomes. (2014) (80)
The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. (2002) (79)
Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread. (2002) (75)
Glycoproteins E and I of Marek's Disease Virus Serotype 1 Are Essential for Virus Growth in Cultured Cells (2001) (74)
Construction and characterization of an equine herpesvirus 1 glycoprotein C negative mutant. (1999) (73)
A single-nucleotide polymorphism in a herpesvirus DNA polymerase is sufficient to cause lethal neurological disease. (2009) (72)
Herpesviruses--a zoonotic threat? (2010) (71)
Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry (2020) (71)
vLIP, a Viral Lipase Homologue, Is a Virulence Factor of Marek's Disease Virus (2005) (71)
Marek's Disease Viral Interleukin-8 Promotes Lymphoma Formation through Targeted Recruitment of B Cells and CD4+ CD25+ T Cells (2012) (70)
Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain. (1997) (68)
The genome content of Marek's disease-like viruses (2004) (66)
Potential zoonotic sources of SARS‐CoV‐2 infections (2020) (65)
Intrahost Evolutionary Dynamics of Canine Influenza Virus in Naïve and Partially Immune Dogs (2010) (65)
Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant (2011) (64)
The Gene 10 (UL49.5) Product of Equine Herpesvirus 1 Is Necessary and Sufficient for Functional Processing of Glycoprotein M (2002) (64)
Replication kinetics of neurovirulent versus non-neurovirulent equine herpesvirus type 1 strains in equine nasal mucosal explants. (2010) (63)
The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection (2020) (62)
Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH during attenuation. (1996) (61)
Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread. (1997) (60)
Herpesvirus Chemokine-Binding Glycoprotein G (gG) Efficiently Inhibits Neutrophil Chemotaxis In Vitro and In Vivo1 (2007) (55)
The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence. (1996) (55)
Fluorescently Tagged pUL47 of Marek's Disease Virus Reveals Differential Tissue Expression of the Tegument Protein In Vivo (2011) (54)
A Potentially Fatal Mix of Herpes in Zoos (2012) (54)
A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens. (2002) (54)
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2 (2020) (52)
Multi‐species ELISA for the detection of antibodies against SARS‐CoV‐2 in animals (2020) (52)
Canine distemper virus in the Serengeti ecosystem: molecular adaptation to different carnivore species (2016) (51)
Functionalized nanographene sheets with high antiviral activity through synergistic electrostatic and hydrophobic interactions. (2019) (51)
SARS‐CoV‐2 infection of Chinese hamsters (Cricetulus griseus) reproduces COVID‐19 pneumonia in a well‐established small animal model (2020) (51)
Equine Herpesvirus 1 Entry via Endocytosis Is Facilitated by αV Integrins and an RSD Motif in Glycoprotein D (2008) (51)
Detection of Chelonid Herpesvirus DNA by Nonradioactive in Situ Hybridization in Tissues from Tortoises Suffering from Stomatitis—Rhinitis Complex in Europe and North America (2000) (50)
Equine infectious diseases. (2013) (49)
Identification and Characterization of Equine Herpesvirus Type 1 pUL56 and Its Role in Virus-Induced Downregulation of Major Histocompatibility Complex Class I (2012) (47)
An Equine Herpesvirus Type 1 (EHV-1) Expressing VP2 and VP5 of Serotype 8 Bluetongue Virus (BTV-8) Induces Protection in a Murine Infection Model (2012) (47)
In vitro model for lytic replication, latency, and transformation of an oncogenic alphaherpesvirus (2015) (46)
Experimental infection with equine herpesvirus type 1 (EHV-1) induces chorioretinal lesions (2013) (45)
Comparison of two trapping methods for Culicoides biting midges and determination of African horse sickness virus prevalence in midge populations at Onderstepoort, South Africa. (2012) (45)
Size-dependent inhibition of herpesvirus cellular entry by polyvalent nanoarchitectures. (2017) (45)
Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2–infected Hamsters: What Matters? (2020) (45)
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model (2020) (45)
Clinical observations and management of a severe equine herpesvirus type 1 outbreak with abortion and encephalomyelitis (2013) (45)
Glycoproteins D of Equine Herpesvirus Type 1 (EHV-1) and EHV-4 Determine Cellular Tropism Independently of Integrins (2011) (44)
Detection of equine herpesvirus-1 in nasal swabs of horses by quantitative real-time PCR. (2008) (44)
Herpesvirus Telomerase RNA (vTR) with a Mutated Template Sequence Abrogates Herpesvirus-Induced Lymphomagenesis (2011) (44)
SERUM CHEMISTRY AND ANTIBODIES AGAINST PATHOGENS IN ANTARCTIC FUR SEALS, WEDDELL SEALS, CRABEATER SEALS, AND ROSS SEALS (2012) (43)
High-Level Expression of Marek's Disease Virus Glycoprotein C Is Detrimental to Virus Growth In Vitro (2005) (43)
The equine herpesvirus 1 UL34 gene product is involved in an early step in virus egress and can be efficiently replaced by a UL34-GFP fusion protein. (2002) (43)
Mutagenesis of a bovine herpesvirus type 1 genome cloned as an infectious bacterial artificial chromosome: analysis of glycoprotein E and G double deletion mutants. (2003) (42)
Report of the equine herpesvirus-1 Havermeyer Workshop, San Gimignano, Tuscany, June 2004. (2006) (42)
The Truncated Form of Glycoprotein gp2 of Equine Herpesvirus 1 (EHV-1) Vaccine Strain KyA Is Not Functionally Equivalent to Full-Length gp2 Encoded by EHV-1 Wild-Type Strain RacL11 (2004) (41)
Herpesvirus Telomerase RNA(vTR)-Dependent Lymphoma Formation Does Not Require Interaction of vTR with Telomerase Reverse Transcriptase (TERT) (2010) (41)
Complete genome sequence of virulent duck enteritis virus (DEV) strain 2085 and comparison with genome sequences of virulent and attenuated DEV strains. (2011) (41)
Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome. (2010) (41)
Potential of Equine Herpesvirus 1 as a Vector for Immunization (2005) (40)
Generation of a permanent cell line that supports efficient growth of Marek's disease virus (MDV) by constitutive expression of MDV glycoprotein E. (2002) (40)
Mechanism of Virus Attenuation by Codon Pair Deoptimization. (2020) (40)
Enzymatically inactive U(S)3 protein kinase of Marek's disease virus (MDV) is capable of depolymerizing F-actin but results in accumulation of virions in perinuclear invaginations and reduced virus growth. (2008) (39)
In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG). (2007) (39)
Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains. (2011) (39)
Further Analysis of Marek's Disease Virus Horizontal Transmission Confirms That UL44 (gC) and UL13 Protein Kinase Activity Are Essential, while US2 Is Nonessential (2010) (39)
Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection. (1997) (39)
The Equine Herpesvirus 1 US2 Homolog Encodes a Nonessential Membrane-Associated Virion Component (1999) (38)
Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cells. (2010) (38)
Antagonistic Pleiotropy and Fitness Trade-Offs Reveal Specialist and Generalist Traits in Strains of Canine Distemper Virus (2012) (38)
Attenuation of a very virulent Marek's disease herpesvirus (MDV) by codon pair bias deoptimization (2018) (37)
The α-TIF (VP16) Homologue (ETIF) of Equine Herpesvirus 1 Is Essential for Secondary Envelopment and Virus Egress (2006) (37)
Equine herpesvirus 1 (EHV-1) glycoprotein M: effect of deletions of transmembrane domains. (2000) (36)
Strain impact on equine herpesvirus type 1 (EHV-1) abortion models: viral loads in fetal and placental tissues and foals. (2012) (36)
How Host Specific Are Herpesviruses? Lessons from Herpesviruses Infecting Wild and Endangered Mammals. (2018) (36)
A severe equine herpesvirus type 1 (EHV-1) abortion outbreak caused by a neuropathogenic strain at a breeding farm in northern Germany. (2014) (36)
Generation of an infectious clone of duck enteritis virus (DEV) and of a vectored DEV expressing hemagglutinin of H5N1 avian influenza virus. (2011) (35)
Equine alphaherpesviruses (EHV-1 and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants. (2011) (35)
Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model of Persistent Varicella-Zoster Virus Infection (2013) (35)
Effective Treatment of Respiratory Alphaherpesvirus Infection Using RNA Interference (2009) (35)
Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV). (2007) (34)
High-dose dietary zinc oxide mitigates infection with transmissible gastroenteritis virus in piglets (2014) (34)
Epithelial response to IFN‐γ promotes SARS‐CoV‐2 infection (2021) (34)
Equine Herpesvirus 1 Utilizes a Novel Herpesvirus Entry Receptor (2005) (34)
Varicella-Zoster Virus Open Reading Frame 66 Protein Kinase Is Required for Efficient Viral Growth in Primary Human Corneal Stromal Fibroblast Cells (2008) (34)
A phylogenomic analysis of Marek's disease virus reveals independent paths to virulence in Eurasia and North America (2017) (34)
Out of the Reservoir: Phenotypic and Genotypic Characterization of a Novel Cowpox Virus Isolated from a Common Vole (2015) (34)
Graphene Sheets with Defined Dual Functionalities for the Strong SARS‐CoV‐2 Interactions (2021) (33)
Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza. (2008) (33)
Identification of Binding Sites for Neutralizing Monoclonal Antibodies on the 14-kDa Fusion Protein of Orthopox Viruses (1994) (33)
Zebra-borne equine herpesvirus type 1 (EHV-1) infection in non-African captive mammals. (2014) (33)
Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD. (1998) (33)
Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek’s disease virus (MDV) (2010) (32)
Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. (2007) (32)
Down-regulation of MHC class I by the Marek's disease virus (MDV) UL49.5 gene product mildly affects virulence in a haplotype-specific fashion. (2010) (31)
Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression. (2011) (31)
CCL3 and Viral Chemokine-Binding Protein gG Modulate Pulmonary Inflammation and Virus Replication during Equine Herpesvirus 1 Infection (2007) (31)
A full UL13 open reading frame in Marek's disease virus (MDV) is dispensable for tumor formation and feather follicle tropism and cannot restore horizontal virus transmission of rRB-1B in vivo. (2007) (31)
Equine Herpesvirus Type 4 UL56 and UL49.5 Proteins Downregulate Cell Surface Major Histocompatibility Complex Class I Expression Independently of Each Other (2012) (30)
Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model. (2002) (30)
A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus. (2010) (30)
Bats, Primates, and the Evolutionary Origins and Diversification of Mammalian Gammaherpesviruses (2016) (30)
Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain (2008) (29)
Synthesis and processing of the equine herpesvirus 1 glycoprotein M. (1997) (29)
Equine herpesvirus type 1 modified live virus vaccines: quo vaditis? (2006) (29)
Serological Survey in Dogs and Cats for Influenza A(H1N1)pdm09 in Germany (2012) (28)
Equine herpesvirus type 1 (EHV-1) glycoprotein K is required for efficient cell-to-cell spread and virus egress. (2004) (28)
The Equine Herpesvirus 1 IR6 Protein That Colocalizes with Nuclear Lamins Is Involved in Nucleocapsid Egress and Migrates from Cell to Cell Independently of Virus Infection (1998) (28)
Long term stability and infectivity of herpesviruses in water (2017) (28)
Expression of the Full-Length Form of gp2 of Equine Herpesvirus 1 (EHV-1) Completely Restores Respiratory Virulence to the Attenuated EHV-1 Strain KyA in CBA Mice (2005) (27)
Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding (2021) (26)
Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines. (2012) (26)
Viral genes and cellular markers associated with neurological complications during herpesvirus infections. (2017) (26)
Glycoprotein H and α4β1 Integrins Determine the Entry Pathway of Alphaherpesviruses (2013) (25)
Equid Herpesvirus Type 1 Activates Platelets (2015) (25)
Varicella-zoster virus—induced apoptosis in MeWo cells is accompanied by down-regulation of Bcl-2 expression (2010) (25)
Equine herpesvirus type 1 pUL56 modulates innate responses of airway epithelial cells. (2014) (25)
Meningoencephalitis in Mice Infected with an Equine Herpesvirus 1 Strain KyA Recombinant Expressing Glycoprotein I and Glycoprotein E (2004) (25)
Marek's Disease Virus Expresses Multiple UL44 (gC) Variants through mRNA Splicing That Are All Required for Efficient Horizontal Transmission (2012) (24)
Comprehensive Serology Based on a Peptide ELISA to Assess the Prevalence of Closely Related Equine Herpesviruses in Zoo and Wild Animals (2015) (24)
Binding of Alphaherpesvirus Glycoprotein H to Surface α4β1-Integrins Activates Calcium-Signaling Pathways and Induces Phosphatidylserine Exposure on the Plasma Membrane (2015) (24)
Alphaherpesviruses and Chemokines: Pas de Deux Not Yet Brought to Perfection (2008) (24)
A touchdown PCR for the differentiation of equine herpesvirus type 1 (EHV-1) field strains from the modified live vaccine strain RacH. (1994) (24)
Development of a peptide ELISA for discrimination between serological responses to equine herpesvirus type 1 and 4. (2013) (23)
Dietary Enterococcus faecium NCIMB 10415 and Zinc Oxide Stimulate Immune Reactions to Trivalent Influenza Vaccination in Pigs but Do Not Affect Virological Response upon Challenge Infection (2014) (23)
Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies. (2008) (22)
Prevalence of equine gammaherpesviruses on breeding farms in Turkey and development of a TaqMan MGB real-time PCR to detect equine herpesvirus 5 (EHV-5) (2014) (22)
Differentiation of species of the genus Orthopoxvirus in a dot blot assay using digoxigenin-labeled DNA-probes. (1993) (21)
Expression of equine herpesvirus type 1 glycoprotein gp14 in Escherichia coli and in insect cells: a comparative study on protein processing and humoral immune responses. (1994) (21)
Lessons from gene knockouts. (1998) (21)
The equine herpesvirus 1 IR6 protein is nonessential for virus growth in vitro and modified by serial virus passage in cell culture. (1996) (21)
The Varicella-Zoster Virus ORFS/L (ORF0) Gene Is Required for Efficient Viral Replication and Contains an Element Involved in DNA Cleavage (2010) (20)
Initial Contact: The First Steps in Herpesvirus Entry. (2017) (20)
Equine herpesvirus type 1 infection induces procoagulant activity in equine monocytes (2013) (20)
Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta) (2021) (20)
Recovery of infectious virus from full-length cowpox virus (CPXV) DNA cloned as a bacterial artificial chromosome (BAC) (2011) (20)
Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model (2015) (20)
An enzyme-linked immunosorbent assay (ELISA) for detection of Marek's disease virus-specific antibodies and its application in an experimental vaccine trial. (2004) (20)
Analysis of the Herpesvirus Chemokine-binding Glycoprotein G Residues Essential for Chemokine Binding and Biological Activity* (2009) (20)
Zebra Alphaherpesviruses (EHV-1 and EHV-9): Genetic Diversity, Latency and Co-Infections (2016) (19)
[Establishment and use of infectious bacterial artificial chromosome (BAC) DNA clones of animal herpesviruses]. (2003) (19)
An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep (2017) (19)
Generation of a Complete Single-Gene Knockout Bacterial Artificial Chromosome Library of Cowpox Virus and Identification of Its Essential Genes (2013) (18)
Deletion of gene 52 encoding glycoprotein M of equine herpesvirus type 1 strain RacH results in increased immunogenicity. (2001) (18)
Venereal shedding of equid herpesvirus-1 (EHV-1) in naturally infected stallions. (2012) (17)
Major Histocompatibility Complex Class I Downregulation Induced by Equine Herpesvirus Type 1 pUL56 Is through Dynamin-Dependent Endocytosis (2014) (17)
Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09. (2013) (17)
Comparative Analysis of Glycoprotein B (gB) of Equine Herpesvirus Type 1 and Type 4 (EHV-1 and EHV-4) in Cellular Tropism and Cell-to-Cell Transmission (2015) (16)
Equine Herpesvirus 1 Multiply Inserted Transmembrane Protein pUL43 Cooperates with pUL56 in Downregulation of Cell Surface Major Histocompatibility Complex Class I (2015) (16)
Surfactants – Compounds for inactivation of SARS-CoV-2 and other enveloped viruses (2021) (16)
Herpesviruses of Horses (2008) (16)
Physiological costs of infection: herpesvirus replication is linked to blood oxidative stress in equids (2018) (16)
A Deletion Within Glycoprotein L of Marek's Disease Virus (MDV) Field Isolates Correlates with a Decrease in Bivalent MDV Vaccine Efficacy in Contact-Exposed Chickens (2009) (16)
The effect of siRNA treatment on experimental equine herpesvirus type 1 (EHV-1) infection in horses (2009) (15)
Sequence and initial characterization of the UL10 (glycoprotein M) and UL11 homologous genes of serotype 1 Marek’s Disease Virus (2014) (15)
Generation and characterization of an EICP0 null mutant of equine herpesvirus 1. (2003) (15)
Detection of equid herpesviruses among different Arabian horse populations in Egypt (2019) (15)
A proofreading-impaired herpesvirus generates populations with quasispecies-like structure (2019) (15)
Viruses of protozoan parasites and viral therapy: Is the time now right? (2020) (15)
Characterization of the gene encoding the A-type inclusion body protein of mousepox virus (2005) (15)
A novel endogenous betaretrovirus group characterized from polar bears (Ursus maritimus) and giant pandas (Ailuropoda melanoleuca). (2013) (14)
Transgene expression in the genome of Middle East respiratory syndrome coronavirus based on a novel reverse genetics system utilizing Red-mediated recombination cloning. (2017) (14)
Use of real-time quantitative reverse transcription polymerase chain reaction for the detection of African horse sickness virus replication in Culicoides imicola. (2011) (14)
An equine herpesvirus 1 (EHV-1) vectored H1 vaccine protects against challenge with swine-origin influenza virus H1N1. (2011) (14)
Inhibition of Herpes Simplex Virus Type 1 Attachment and Infection by Sulfated Polyglycerols with Different Architectures. (2021) (14)
Equid herpesvirus 1 (EHV1) infection of equine mesenchymal stem cells induces a pUL56-dependent downregulation of select cell surface markers. (2015) (13)
The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding (2012) (13)
A Point Mutation in a Herpesvirus Co-Determines Neuropathogenicity and Viral Shedding (2017) (13)
West Nile Virus Antibody Prevalence in Horses in Ukraine (2013) (13)
[Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation]. (1999) (13)
Marek's disease virus (MDV) ubiquitin-specific protease (USP) performs critical functions beyond its enzymatic activity during virus replication. (2013) (13)
The ORF012 Gene of Marek's Disease Virus Type 1 Produces a Spliced Transcript and Encodes a Novel Nuclear Phosphoprotein Essential for Virus Growth (2014) (13)
Detection of Marek's Disease Virus DNA in Chicken but Not in Human Plasma (2003) (13)
The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses (2018) (11)
Fatal Elephant Endotheliotropic Herpesvirus Infection of Two Young Asian Elephants (2019) (11)
Genome-wide association study of equine herpesvirus type 1-induced myeloencephalopathy identifies a significant single nucleotide polymorphism in a platelet-related gene. (2019) (10)
The Marek’s disease virus (MDV) protein encoded by the UL17 ortholog is essential for virus growth (2009) (10)
The role of secreted glycoprotein G of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in immune modulation and virulence. (2012) (10)
A hepatitis B virus causes chronic infections in equids worldwide (2021) (10)
Experimental Cowpox Virus (CPXV) Infections of Bank Voles: Exceptional Clinical Resistance and Variable Reservoir Competence (2017) (10)
An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease (2019) (10)
Phocine herpesvirus 1 (PhHV-1) in harbor seals from Svalbard, Norway. (2013) (9)
Simian varicella virus open reading frame 63/70 expression is required for efficient virus replication in culture (2011) (9)
Polar bear encephalitis: establishment of a comprehensive next-generation pathogen analysis pipeline for captive and free-living wildlife. (2014) (9)
ACE2-Variants Indicate Potential SARS-CoV-2-Susceptibility in Animals: An Extensive Molecular Dynamics Study (2020) (9)
Equine herpesvirus type 1 (EHV-1) open reading frame 59 encodes an early protein that is localized to the cytosol and required for efficient virus growth. (2014) (8)
Equid herpesvirus type 4 uses a restricted set of equine major histocompatibility complex class I proteins as entry receptors. (2014) (8)
Novel Divergent Polar Bear-Associated Mastadenovirus Recovered from a Deceased Juvenile Polar Bear (2018) (8)
Ubiquitination and degradation of the ORF34 gene product of equine herpesvirus type 1 (EHV-1) at late times of infection. (2014) (8)
Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D. (2003) (8)
Equine Herpesvirus Type 1 Modulates Cytokine and Chemokine Profiles of Mononuclear Cells for Efficient Dissemination to Target Organs (2020) (8)
Attenuation of Viruses by Large-Scale Recoding of their Genomes: the Selection Is Always Biased (2018) (8)
Subclinical infection of a young captive Asian elephant with elephant endotheliotropic herpesvirus 1 (2018) (8)
Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity (2018) (8)
Cell Biology of Herpes Viruses (2017) (7)
What a Difference a Gene Makes: Identification of Virulence Factors of Cowpox Virus (2019) (7)
A Deletion in the Glycoprotein L (gL) Gene of U.S. Marek's Disease Virus (MDV) Field Strains Is Insufficient to Confer Increased Pathogenicity to the Bacterial Artificial Chromosome (BAC)–Based Strain, RB-1B (2013) (7)
Cowpox virus serpin CrmA is necessary but not sufficient for the red pock phenotype on chicken chorioallantoic membranes. (2012) (7)
Herpesviruses of Birds (2008) (7)
Noninvasive Detection of Equid Herpesviruses in Fecal Samples (2018) (7)
Identification of 10 Cowpox Virus Proteins That Are Necessary for Induction of Hemorrhagic Lesions (Red Pocks) on Chorioallantoic Membranes (2014) (7)
Palmitoylation of the envelope membrane proteins GP5 and M of porcine reproductive and respiratory syndrome virus is essential for virus growth (2021) (7)
Histopathological and Immunohistochemical Studies of Cowpox Virus Replication in a Three-Dimensional Skin Model. (2016) (7)
Residue 752 in DNA polymerase of equine herpesvirus type 1 is non-essential for virus growth in vitro. (2010) (7)
Treatment of EHV-1 infection using RNA interference (2008) (6)
The US3 Kinase of Herpes Simplex Virus Phosphorylates the RNA Sensor RIG-I To Suppress Innate Immunity (2021) (6)
Molecular characterization of the equine herpesvirus 1 strains RacL11 and Kentucky D. (2007) (6)
Codon pair bias deoptimization of the major oncogene meq of a very virulent Marek's disease virus. (2018) (6)
The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires (2015) (6)
Prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease‐19 pandemic (2022) (6)
Differentially-Charged Liposomes Interact with Alphaherpesviruses and Interfere with Virus Entry (2020) (6)
One-pot gram-scale synthesis of virucidal heparin-mimicking polymers as HSV-1 inhibitors. (2021) (6)
The recombinant EHV-1 vector producing CDV hemagglutinin as potential vaccine against canine distemper. (2017) (5)
Graphene‐Assisted Synthesis of 2D Polyglycerols as Innovative Platforms for Multivalent Virus Interactions (2021) (5)
Properties of an equine herpesvirus 1 mutant devoid of the internal inverted repeat sequence of the genomic short region. (2011) (5)
Report of the Fourth International Havemeyer Workshop on Equid Herpesviruses (EHV) EHV-1, EHV-2 and EHV-5. (2019) (5)
Elevated dietary zinc oxide levels do not have a substantial effect on porcine reproductive and respiratory syndrome virus (PPRSV) vaccination and infection (2014) (5)
Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses. (2013) (5)
SARS‐CoV‐2 Inhibitors: Graphene Sheets with Defined Dual Functionalities for the Strong SARS‐CoV‐2 Interactions (Small 11/2021) (2021) (5)
Equine Alphaherpesviruses Require Activation of the Small GTPases Rac1 and Cdc42 for Intracellular Transport (2020) (5)
EHV-1 Pathogenesis: Current in vitro Models and Future Perspectives (2019) (5)
Construction and manipulation of a full-length infectious bacterial artificial chromosome clone of equine herpesvirus type 3 (EHV-3). (2017) (4)
Prevention of equine herpesvirus myeloencephalopathy - Is heparin a novel option? A case report. (2016) (4)
Impact of ETIF Deletion on Safety and Immunogenicity of Equine Herpesvirus Type 1-Vectored Vaccines (2010) (4)
Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020 (2022) (4)
Investigation of neurologic equine herpes virus 1 epidemiology from 1984-2007 (2008) (4)
Equine Herpesvirus Type 4 (EHV-4) Outbreak in Germany: Virological, Serological, and Molecular Investigations (2021) (4)
Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines—A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters (2021) (4)
Seasonal host and ecological drivers may promote restricted water as a viral vector. (2021) (4)
EHV-1 Consensus Statement Equine Herpesvirus-1 Consensus Statement (2009) (4)
Glycoprotein B of equine herpesvirus type 1 has two recognition sites for subtilisin-like proteases that are cleaved by furin. (2016) (4)
Equine herpesvirus 1 and 4 differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants (2011) (3)
Correction to: Herpesvirus DNA Polymerase Mutants—How Important Is Faithful Genome Replication? (2019) (3)
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study (2021) (3)
The Roborovski Dwarf Hamster – A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection (2020) (3)
Synthetically recoded virus sCPD9 – A tool to accelerate SARS-CoV-2 research under biosafety level 2 conditions (2022) (2)
ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study (2021) (2)
Equine Herpesviruses and Interspecies Infections (2019) (2)
SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression (2022) (2)
Equine herpesvirus type 1 (EHV1) induces alterations in the immunophenotypic profile of equine monocyte-derived dendritic cells. (2016) (2)
Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line (2021) (1)
A live attenuated vaccine confers superior mucosal and systemic immunity to SARS-CoV-2 variants (2022) (1)
Author Correction: A proofreading-impaired herpesvirus generates populations with quasispecies-like structure (2019) (1)
Fast-forwarding evolution—Accelerated adaptation in a proofreading-deficient hypermutator herpesvirus (2022) (1)
Bearing the brunt: Mongolian khulan (Equus hemionus hemionus) are exposed to multiple influenza A strains. (2020) (1)
Replication of cowpox virus in macrophages is dependent on the host range factor p28/N1R (2021) (1)
Immune Dogs Influenza Virus in Naïve and Partially Intrahost Evolutionary Dynamics of Canine (2014) (1)
Elevated dietary zinc oxide levels do not have a substantial effect on porcine reproductive and respiratory syndrome virus (PPRSV) vaccination and infection (2014) (1)
Construction and manipulation of a full-length infectious bacterial artificial chromosome clone of equine herpesvirus type 3 (2016) (1)
Viruses of protozoan parasites and viral therapy: Is the time now right? (2020) (0)
Equine herpesvirus type 1 (EHV-1) conquers and reprograms mononuclear cells to ensure transfer to endothelial cells (2016) (0)
Vaccines against viruses of Marek's disease (mdv) and varicella zoster virus. (2001) (0)
Identification of new Orthopoxvirus virulence markers in the rodent host (2015) (0)
Aus dem Institut für Virologie des Fachbereichs Veterinärmedizin der Freien Universität Berlin Membrane Topology and Processing of the Minor Glycoproteins of Equine Arteritis Virus Inaugural-Dissertation zur Erlangung des Grades eines Ph.D. am Fachbereich Veterinärmedizin an der Freien Universit (2014) (0)
Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity (2017) (0)
Differentially-Charged Phospholipids Interact with Alphaherpesviruses and Interfere with Virus Entry (2020) (0)
Peptide motifs for Major Histocompatibility Complex class I molecules of the horse (2016) (0)
How do we prevent and control future outbreaks of equine herpesvirus myeloencephalopathy at equestrian gatherings? (2023) (0)
Replication of cowpox virus in macrophages is dependent on the host range factor p28/N1R (2021) (0)
Lessons from qene knockouts (1998) (0)
Equine Herpesvirus-1 Consensus Statement. In: ACVIM Consensus Statement Guidelines (2009) (0)
Virus vaccine for Marek's disease (MDV) and varicella zoster virus (VZV). (2001) (0)
Highly pathogenic H 5 N 1 avian influenza virus epidemic in Egypt : Detection and protection studies Inaugural (2012) (0)
Running title : Multi-species ELISA for SARS-CoV-2 antibodies 2 3 (2020) (0)
The herpesvirus stealth program (2015) (0)
SARS‐CoV‐2 vaccination—A plea for fast and coordinated action (2020) (0)
Physiological costs of infection: herpesvirus replication is linked to blood oxidative stress in equids (2018) (0)
Crystal structure of glycoprotein D of Equine Herpesvirus Type 4 (2020) (0)
Herpesvirus DNA Polymerase Mutants—How Important Is Faithful Genome Replication? (2019) (0)
The Molecular Character and Comparison with German EHV-1 Viruses of Equine Herpes Virus Isolated from izmit Region (1996) (0)
Peptide-binding motifs of two common equine class I MHC molecules in Thoroughbred horses (2017) (0)
Engineering and Characterization of Avian Coronavirus Mutants Expressing Fluorescent Reporter Proteins from the Replicase Gene (2022) (0)
Herpesvirus chemokine binding protein gG efficiently inhibits neutrophil chemotaxis in vitro and in vivo (2014) (0)
Vaccination against Borna Disease: Overview, Vaccine Virus Characterization and Investigation of Live and Inactivated Vaccines (2022) (0)
Correction: Equid Herpesvirus Type 1 Activates Platelets (2020) (0)
Peptide-binding motifs of two common equine class I MHC molecules in Thoroughbred horses (2017) (0)
Profiling chemokine–glycoprotein G interactions: implications for alphaherpesviral immune evasion (2012) (0)
Subclinical infection of a young captive Asian elephant with elephant endotheliotropic herpesvirus 1 (2017) (0)
Effect of Insertion and Deletion in the Meq Protein Encoded by Highly Oncogenic Marek’s Disease Virus on Transactivation Activity and Virulence (2022) (0)
The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires (2015) (0)
Varicellovirus UL49.5-encoded TAP inhibitors: one family, one target, but diverse mechanisms (2007) (0)
An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep (2017) (0)
Crystal structures of glycoprotein D of equine alphaherpesviruses reveal potential binding sites to the entry receptor MHC-I (2022) (0)
Cloning and mutagenesis of the Bovine Herpes virus Type I genome as an infectious bacterial artificial chromosome (BAC) (2002) (0)
Optimized antigen expression and presentation for diagnostic purposes – a new potential for Equine Herpesvirus 1 as a vector (2015) (0)
Fomite Transmission of SARS-CoV-2 and Its Contributing Factors (2023) (0)
Varicella-Zoster Virus Open Reading Frame 66 Protein Kinase Is Required for Efﬁcient Viral Growth in Primary Human Corneal Stromal Fibroblast Cells (cid:1) (2008) (0)
Identification and characterization of equine herpesvirus type 1 ( EHV-1 ) pUL 56 and its role in 1 virus-induced downregulation of MHC class I 2 3 (2012) (0)
Three-dimensional normal human neural progenitor tissue-like assemblies: A model for persistent Varicella-zoster virus infection and platform to study oxidate stress and damage in multiple hit scenarios (2015) (0)
MINIREVIEW Alphaherpesviruses and Chemokines: Pas de Deux Not Yet Brought to Perfection (cid:1) (2008) (0)
Evaluation of immunity and clinical disease following infection of horses with Equine herpesvirus-1 and mutants of differing neuropathogenic potential (2016) (0)
The Varicella-Zoster Virus ORFS/L (ORF0) Gene Is Required for Efﬁcient Viral Replication and Contains an Element Involved in DNA Cleavage (cid:1) (2010) (0)
Correction to: Herpesvirus DNA Polymerase Mutants—How Important Is Faithful Genome Replication? (2020) (0)
Use of real-time quantitative reverse transcription polymerase chain reaction for the detection of African horse sickness virus replication in Culicoides imicola : original research (2011) (0)
Prevalence of equine gammaherpesviruses on breeding farms in Turkey and development of a TaqMan MGB real-time PCR to detect equine herpesvirus 5 (EHV-5) (2014) (0)
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters (2023) (0)
Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model for Persistent Varicell-Zoster Virus Infection and Platform to Study Viral Infectivity and Oxidative Stress and Damage (2014) (0)
R code file (2017) (0)
Late‐Term Abortion, Stillbirth, and Neonatal Foal Death in Kyrgyzstan: First Isolation of Equine Herpesvirus Type 1 in the Country (2017) (0)
Cowpox virus virulence factors - genetic definition and in vivo testing (2015) (0)
Detection of phocine herpesvirus 1 in seals from populations in different environments (2012) (0)
Correction to "Inhibition of Herpes Simplex Virus Type 1 Attachment and Infection by Sulfated Polyglycerols with Different Architectures". (2021) (0)
A Deletion within Glycoprotein L of Marek's Disease Virus (MDV) Field Isolates Correlates with A Decrease in Bivalent MDV Vaccine Efficacy in Contact-exposed Chickens (2009) (0)
Attenuation of Viruses by Large-Scale Recoding of their Genomes: the Selection Is Always Biased (2018) (0)
Marek’s Disease Viral Interleukin-8 Promotes Lymphoma Formation through Targeted Recruitment of B Cells and CD4 (cid:1) CD25 (cid:1) T Cells (2012) (0)
Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection. (2020) (0)
Susceptibility of Vero E6 cells to Tilapia Lake virus (TiLV) and anti-TiLV activity of type I interferon (2023) (0)
A continuous cell line for the production of vaccines: WO03066093 (A1) ― 2003-08-14 (2003) (0)
Development of a peptide ELISA for discrimination between serological responses to equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) (2012) (0)
Dynamin-Dependent Endocytosis Herpesvirus Type 1 pUL 56 Is through Downregulation Induced by Equine Major Histocompatibility Complex Class I (2014) (0)
Equine Herpesviruses (Herpesviridae) (2021) (0)
Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals? (2022) (0)
Crystal structure of glycoprotein D of Equine Herpesvirus Type 1 (2020) (0)
Biological Activity Residues Essential for Chemokine Binding Chemokine-binding Glycoprotein G Analysis of the Herpesvirus Protein Structure and Folding : (2009) (0)

This paper list is powered by the following services:

Other Resources About Nikolaus Osterrieder

scholars.cityu.edu.hk

What Schools Are Affiliated With Nikolaus Osterrieder?

Nikolaus Osterrieder is affiliated with the following schools:

Ludwig Maximilian University of Munich
City University of Hong Kong
Free University of Berlin
Cornell University
University of Zurich

Nikolaus Osterrieder's Academic­Influence.com Rankings

Why Is Nikolaus Osterrieder Influential?

Nikolaus Osterrieder's Published Works

Published Works

Other Resources About Nikolaus Osterrieder

What Schools Are Affiliated With Nikolaus Osterrieder?

Nikolaus Osterrieder's AcademicInfluence.com Rankings